Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cilostazol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced Pd-catalyzed synthesis of 6-hydroxy-3,4-dihydro-2(1H)-quinolinone. Enhances yield and reduces steps for Cilostazol intermediate manufacturing.
Patent CN1553908A details a breakthrough water-based process for cilostazol, offering high purity and yield while eliminating hazardous organic solvents for cost-effective manufacturing.
Discover the patented aqueous synthesis method for Cilostazol (CN1257902C). Achieve >99% purity with reduced environmental impact and optimized manufacturing costs.
Patent CN105111190A reveals safer Cilostazol synthesis reducing hazardous reagents. Enhances supply chain reliability and cost efficiency for pharmaceutical manufacturing partners globally.
Patent CN1469864A details improved alkylation methods using phase transfer or buffered inorganic bases, enhancing yield and reducing costs for pharmaceutical intermediates.